Table 4 Cell cycle distribution of HepG2 cells after treatment with or without RES for 48 h

HepG2

76.3

9.6

14.1

73.0

13.5

13.5

25.3

4.8

69.9*

34.9

7.4

57.7*

72.7*

8.8

18.5

CAV1

57.9

10.0

32.1

15.4

7.5

77.1*

27.5

21.4

51.1*

65.8*

1.6

32.6

73.5*

24.2

2.3

CAVM1

58.9

16.0

25.0

69.5

8.9

21.6

33.9

10.5

55.7*

39.9

20.0

40.1*

79*

8.6

12.4

CAVM2

68.2

11.1

20.7

72.5

3.8

23.7

30.5

8.4

61.1*

75.8*

3.1

21.1

74.1*

8.5

17.4

CAVRNAi

57.8

10.2

38.1

45.3

16.4

32.3

37.5

21.1

55.0*

64.9*

19.5

15.7

69.2*

13.1

17.7

GFP

77.4

5.9

16.7

73.2

14.0

12.5

22.3

6.0

71.7*

30.4

7.8

61.8*

70.0*

10.5

20.5